Rheumatology NewsLow-dose methotrexate trial pins down adverse event ratesFebruary 18, 2020Rheumatoid ArthritisPsoriatic Arthritis
Rheumatology NewsValue of very early etanercept plus methotrexate not confirmed in real-world RA trialFebruary 4, 2020Rheumatoid Arthritis
Rheumatology NewsMultiple assessment measures can hone RA treatmentFebruary 4, 2020Rheumatoid Arthritis
Rheumatology NewsIn rheumatology, biosimilars are flatlining. Why?January 27, 2020Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsWhat happens to clinically suspected arthralgia patients without RA?January 21, 2020Rheumatoid Arthritis
Rheumatology NewsValue analysis of JAK inhibitors for RA hampered by limited dataJanuary 17, 2020Rheumatoid Arthritis
Rheumatology NewsIdeal management of RA in pregnancy improves outcomesJanuary 8, 2020Rheumatoid Arthritis
Rheumatology NewsNearly 25% of U.S. adults take an obesogenic prescription drugJanuary 3, 2020Lupus & Connective Tissue DiseasesRheumatoid Arthritis
Rheumatology NewsDose escalation of biosimilar infliximab for RA patients deemed cost effective, to a pointDecember 20, 2019Rheumatoid Arthritis
Rheumatology NewsSwitch to biologic for RA more about prescribers than patientsDecember 13, 2019Rheumatoid Arthritis
Rheumatology NewsRepeat LTBI testing best in patients taking biologics with new risk factorsDecember 9, 2019Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisLupus & Connective Tissue Diseases
Rheumatology NewsPerioperative antirheumatic drug use does not impact postsurgery infection rate in RA patientsDecember 9, 2019Rheumatoid ArthritisMixed Topics
Rheumatology NewsFDA approves infliximab-axxq for numerous indicationsDecember 6, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsCertolizumab safety profile varies widely across indicationsNovember 27, 2019Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Rheumatology NewsMore studies like VERVE needed to test live vaccines in special populationsNovember 25, 2019Rheumatoid ArthritisAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
